CD22 POSITIVE

Clinical trials for CD22 POSITIVE explained in plain language.

Never miss a new study

Get alerted when new CD22 POSITIVE trials appear

Sign up with your email to follow new studies for CD22 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

New drug tested for Tough-to-Treat blood cancer

Disease control Terminated

This study tested a new drug called ADCT-602 for adults with a fast-growing blood cancer (B-cell acute lymphoblastic leukemia) that has come back or stopped responding to standard treatments. The main goals were to find a safe and effective dose and to see if the drug could help …

Matched conditions: CD22 POSITIVE

Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

CD22 POSITIVE

Get alerted when new CD22 POSITIVE trials appear

New drug tested for Tough-to-Treat blood cancer